Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-9708

2 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-9708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Dd6b1df6 Addf 4e4b A934 16b28f6cfa9e 01)

Figure (Dd6b1df6 Addf 4e4b A934 16b28f6cfa9e 01)
Chemical structure of diltiazem hydrochloride depicted with distinct aromatic rings, functional groups including methoxy and acetyl groups, and hydrochloride component indicated.*
FDA Label Image

Label (Lbl713359708)

Label (Lbl713359708)
Label for diltiazem hydrochloride extended-release capsules, USP 180 mg, NDC 71335-9708-1. The label indicates 30 capsules in the package, with repackaging by Bryant Ranch Prepack, Inc., Burbank, CA, and manufacturing by Cadila Healthcare Limited. Storage and handling instructions and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.